Identification of a Short Cell-Penetrating Peptide from Bovine Lactoferricin for Intracellular Delivery of DNA in Human A549 Cells

Overview

Journal PLoS One

Specialties General Medicine
Science

Date 2016 Mar 5

PMID 26942714

Citations 11

Authors

Betty R Liu

Yue-Wern Huang

Robert S Aronstam

Han-Jung Lee

Affiliations

Soon will be listed here.

Abstract

Cell-penetrating peptides (CPPs) have been shown to deliver cargos, including protein, DNA, RNA, and nanomaterials, in fully active forms into live cells. Most of the CPP sequences in use today are based on non-native proteins that may be immunogenic. Here we demonstrate that the L5a CPP (RRWQW) from bovine lactoferricin (LFcin), stably and noncovalently complexed with plasmid DNA and prepared at an optimal nitrogen/phosphate ratio of 12, is able to efficiently enter into human lung cancer A549 cells. The L5a CPP delivered a plasmid containing the enhanced green fluorescent protein (EGFP) coding sequence that was subsequently expressed in cells, as revealed by real-time PCR and fluorescent microscopy at the mRNA and protein levels, respectively. Treatment with calcium chloride increased the level of gene expression, without affecting CPP-mediated transfection efficiency. Zeta-potential analysis revealed that positively electrostatic interactions of CPP/DNA complexes correlated with CPP-mediated transport. The L5a and L5a/DNA complexes were not cytotoxic. This biomimetic LFcin L5a represents one of the shortest effective CPPs and could be a promising lead peptide with less immunogenic for DNA delivery in gene therapy.

Citing Articles

A cleavable chimeric peptide with targeting and killing domains enhances LPS neutralization and antibacterial properties against multi-drug resistant E. coli.

Wang Z, Teng D, Mao R, Hao Y, Yang N, Wang X Commun Biol. 2023; 6(1):1170.

PMID: 37973936 PMC: 10654507. DOI: 10.1038/s42003-023-05528-0.

Fine-tuning the cytotoxicity of ruthenium(II) arene compounds to enhance selectivity against breast cancers.

Pereira S, Romano-deGea J, Barbosa A, Costa Lima S, Dyson P, Saraiva M Dalton Trans. 2023; 52(33):11679-11690.

PMID: 37552495 PMC: 10442743. DOI: 10.1039/d3dt02037a.

Cell-Penetrating Peptides for Use in Development of Transgenic Plants.

Liu B, Chen C, Huang Y, Lee H Molecules. 2023; 28(8).

PMID: 37110602 PMC: 10142301. DOI: 10.3390/molecules28083367.

Fluid-Phase Endocytosis and Lysosomal Degradation of Bovine Lactoferrin in Lung Cells.

Sayers E, Palmer I, Hope L, Hope P, Watson P, Jones A Pharmaceutics. 2022; 14(4).

PMID: 35456688 PMC: 9032238. DOI: 10.3390/pharmaceutics14040855.

Bio-Membrane Internalization Mechanisms of Arginine-Rich Cell-Penetrating Peptides in Various Species.

Liu B, Chiou S, Huang Y, Lee H Membranes (Basel). 2022; 12(1).

PMID: 35054614 PMC: 8778423. DOI: 10.3390/membranes12010088.

References

Morris M, Vidal P, Chaloin L, Heitz F, Divita G . A new peptide vector for efficient delivery of oligonucleotides into mammalian cells. Nucleic Acids Res. 1997; 25(14):2730-6. PMC: 146800. DOI: 10.1093/nar/25.14.2730. View

Vives E, Brodin P, Lebleu B . A truncated HIV-1 Tat protein basic domain rapidly translocates through the plasma membrane and accumulates in the cell nucleus. J Biol Chem. 1997; 272(25):16010-7. DOI: 10.1074/jbc.272.25.16010. View

Groenink J, van t Hof W, Veerman E, Nieuw Amerongen A . Cationic amphipathic peptides, derived from bovine and human lactoferrins, with antimicrobial activity against oral pathogens. FEMS Microbiol Lett. 1999; 179(2):217-22. DOI: 10.1111/j.1574-6968.1999.tb08730.x. View

Chen C, Chou J, Liu B, Chang M, Lee H . Transfection and expression of plasmid DNA in plant cells by an arginine-rich intracellular delivery peptide without protoplast preparation. FEBS Lett. 2007; 581(9):1891-7. DOI: 10.1016/j.febslet.2007.03.076. View

Hu J, Liu B, Wu C, Lu S, Lee H . Protein transport in human cells mediated by covalently and noncovalently conjugated arginine-rich intracellular delivery peptides. Peptides. 2009; 30(9):1669-78. DOI: 10.1016/j.peptides.2009.06.006. View

Duchardt F, Ruttekolk I, Verdurmen W, Lortat-Jacob H, Burck J, Hufnagel H . A cell-penetrating peptide derived from human lactoferrin with conformation-dependent uptake efficiency. J Biol Chem. 2009; 284(52):36099-36108. PMC: 2794725. DOI: 10.1074/jbc.M109.036426. View

Liu B, Li J, Lu S, Leel H, Huang Y, Shannon K . Cellular internalization of quantum dots noncovalently conjugated with arginine-rich cell-penetrating peptides. J Nanosci Nanotechnol. 2010; 10(10):6534-43. PMC: 2999506. DOI: 10.1166/jnn.2010.2637. View

Liu B, Huang Y, Winiarz J, Chiang H, Lee H . Intracellular delivery of quantum dots mediated by a histidine- and arginine-rich HR9 cell-penetrating peptide through the direct membrane translocation mechanism. Biomaterials. 2011; 32(13):3520-37. DOI: 10.1016/j.biomaterials.2011.01.041. View

Baoum A, Berkland C . Calcium condensation of DNA complexed with cell-penetrating peptides offers efficient, noncytotoxic gene delivery. J Pharm Sci. 2011; 100(5):1637-42. PMC: 4207659. DOI: 10.1002/jps.22407. View

10.

Sanders W, Johnston C, Bridges S, Burgess S, Willeford K . Prediction of cell penetrating peptides by support vector machines. PLoS Comput Biol. 2011; 7(7):e1002101. PMC: 3136433. DOI: 10.1371/journal.pcbi.1002101. View

11.

Wang Y, Xu X, Fan X, Zhang C, Wei Q, Wang X . A cell-penetrating peptide suppresses inflammation by inhibiting NF-κB signaling. Mol Ther. 2011; 19(10):1849-57. PMC: 3188757. DOI: 10.1038/mt.2011.82. View

12.

Liu Y, Han F, Xie Y, Wang Y . Comparative antimicrobial activity and mechanism of action of bovine lactoferricin-derived synthetic peptides. Biometals. 2011; 24(6):1069-78. DOI: 10.1007/s10534-011-9465-y. View

13.

Glogau R, Blitzer A, Brandt F, Kane M, Monheit G, Waugh J . Results of a randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of a botulinum toxin type A topical gel for the treatment of moderate-to-severe lateral canthal lines. J Drugs Dermatol. 2011; 11(1):38-45. View

14.

Iguchi T, Yagi H, Wang C, Sato M . A tightly controlled conditional knockdown system using the Tol2 transposon-mediated technique. PLoS One. 2012; 7(3):e33380. PMC: 3302819. DOI: 10.1371/journal.pone.0033380. View

15.

Silva T, Abengozar M, Fernandez-Reyes M, Andreu D, Nazmi K, Bolscher J . Enhanced leishmanicidal activity of cryptopeptide chimeras from the active N1 domain of bovine lactoferrin. Amino Acids. 2012; 43(6):2265-77. DOI: 10.1007/s00726-012-1304-0. View

16.

Dufourc E, Buchoux S, Toupe J, Sani M, Jean-Francois F, Khemtemourian L . Membrane interacting peptides: from killers to helpers. Curr Protein Pept Sci. 2012; 13(7):620-31. DOI: 10.2174/138920312804142138. View

17.

Fang B, Guo H, Zhang M, Jiang L, Ren F . The six amino acid antimicrobial peptide bLFcin6 penetrates cells and delivers siRNA. FEBS J. 2012; 280(4):1007-17. DOI: 10.1111/febs.12093. View

18.

Gautam A, Chaudhary K, Kumar R, Sharma A, Kapoor P, Tyagi A . In silico approaches for designing highly effective cell penetrating peptides. J Transl Med. 2013; 11:74. PMC: 3615965. DOI: 10.1186/1479-5876-11-74. View

19.

Liu B, Liou J, Huang Y, Aronstam R, Lee H . Intracellular delivery of nanoparticles and DNAs by IR9 cell-penetrating peptides. PLoS One. 2013; 8(5):e64205. PMC: 3665793. DOI: 10.1371/journal.pone.0064205. View

20.

Hilchie A, Vale R, Zemlak T, Hoskin D . Generation of a hematologic malignancy-selective membranolytic peptide from the antimicrobial core (RRWQWR) of bovine lactoferricin. Exp Mol Pathol. 2013; 95(2):192-8. DOI: 10.1016/j.yexmp.2013.07.006. View